论文部分内容阅读
目的观察思连康、思密达联合治疗小儿腹泻的临床疗效。方法 86例小儿腹泻患者随机分为思连康、思密达联合治疗观察组和单纯常规治疗对照组各43例,观察两组治疗疗效。结果观察组总有效率达95.3%,而对照组总有效率为69.8%。结论思连康、思密达联合治疗小儿腹泻病是一种安全有效的方法。
Objective To observe the clinical efficacy of Si Lian Kang and Smecta in the treatment of children with diarrhea. Methods A total of 86 pediatric patients with diarrhea were randomly divided into three groups: Si Lian Kang, Smecta combined treatment group and control group. The curative effect was observed in both groups. Results The total effective rate of observation group was 95.3%, while the control group, the total effective rate was 69.8%. Conclusion Si Lian Kang, Smectite combined treatment of children with diarrhea is a safe and effective method.